Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Investigation

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI89957PMID 28691927PMCID PMC5531412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wuho Is a New Member in Maintaining Genome Stability through its Interaction with Flap Endonuclease 1

  2016cited by this paper
• Mutation in WDR4 impairs tRNA m7G46 methylation and causes a distinct form of microcephalic primordial dwarfism

  2015cited by this paper
• Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy

  2015cited by this paper
• KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination

  2015cited by this paper
• Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

  2015cited by this paper
• Mutation in WDR4 impairs tRNA m7G46 methylation and causes a distinct form of microcephalic primordial dwarfism

  2015cited by this paper
• PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2

  2014cited by this paper
• IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.

  2014cited by this paper
• A dual role for autophagy in a murine model of lung cancer

  2014cited by this paper
• USP11 regulates PML stability to control Notch-induced malignancy in brain tumours

  2014cited by this paper
• PML nuclear bodies: regulation, function and therapeutic perspectives

  2014cited by this paper
• Implication of PMLIV in Both Intrinsic and Innate Immunity

  2014cited by this paper
• SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.

  2014cited by this paper
• p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells

  2013cited by this paper
• Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

  2013cited by this paper
• Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.

  2012cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• CD73: a potent suppressor of antitumor immune responses.

  2012influential reference
• Adenosine promotes alternative macrophage activation via A2A and A2B receptors

  2012cited by this paper
• Molecular and Cellular Pathobiology The SUMOE 3-ligase PIAS 1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA

  2012cited by this paper
• The extracellular matrix: A dynamic niche in cancer progression

  2012cited by this paper
• The role of PML ubiquitination in human malignancies

  2012cited by this paper
• The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.

  2012cited by this paper
• E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.

  2012cited by this paper
• A metabolic prosurvival role for PML in breast cancer.

  2012cited by this paper
• Structure and function of WD40 domain proteins

  2011cited by this paper
• Global identification of modular cullin-RING ligase substrates.

  2011cited by this paper
• Immune microenvironments in solid tumors: new targets for therapy.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression.

  2011cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors

  2010cited by this paper
• Promyelocytic Leukemia Protein Controls Cell Migration in Response to Hydrogen Peroxide and Insulin-like Growth Factor-1*

  2010cited by this paper
• Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth

  2010cited by this paper
• Regulation of cell signalling by uPAR

  2010cited by this paper
• Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

  2010cited by this paper
• The Extracellular Matrix: Not Just Pretty Fibrils

  2009cited by this paper
• PML targeting eradicates quiescent leukaemia-initiating cells

  2009cited by this paper
• Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

  2009cited by this paper
• Serum amyloid A: An acute-phase protein involved in tumour pathogenesis

  2008influential reference
• Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

  2008cited by this paper
• New insights into the role of PML in tumour suppression

  2008cited by this paper
• PML targeting eradicates quiescent leukaemia-initiating cells

  2008cited by this paper
• Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

  2007cited by this paper
• The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR.

  2007cited by this paper
• PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.

  2006cited by this paper
• A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

  2006cited by this paper
• PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR

  2006cited by this paper
• Characterization of endogenous human promyelocytic leukemia isoforms.

  2006cited by this paper
• Molecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machinery

  2006cited by this paper
• CUL4–DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation

  2006cited by this paper
• DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.

  2006cited by this paper
• Urokinase-Receptor (u-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/dormancy, Clinical Outcome and Minimal Residual Disease

  2006cited by this paper
• Immunosuppressive networks in the tumour environment and their therapeutic relevance

  2005cited by this paper
• Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

  2004cited by this paper
• Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

  2004cited by this paper
• Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

  2003influential reference
• Cancer immunoediting: from immunosurveillance to tumor escape

  2002cited by this paper
• Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.

  2002influential reference
• Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

  1997cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types

  year unknowncited by this paper

• Wdr4 regulates ribosome biogenesis and intestinal homeostasis via let-7.

  2026cites this paper
• RNA modifications in cancer

  2025cites this paper
• A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins

  2025cites this paper
• Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies.

  2025cites this paper
• Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy

  2025cites this paper
• Post-translational modifications of proteins: dynamic regulatory network and therapeutic targets of tumor immune escape in pan-cancer.

  2025cites this paper
• Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets

  2024cites this paper
• Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia

  2024cites this paper
• Exploring the role of m7G modification in Cancer: Mechanisms, regulatory proteins, and biomarker potential.

  2024cites this paper
• Nuclear export of PML promotes p53-mediated apoptosis and ferroptosis.

  2024cites this paper
• PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma

  2024cites this paper
• Recent advances in c-Met-based dual inhibitors in the treatment of cancers.

  2024cites this paper
• WDR4 promotes HCC pathogenesis through N7-methylguanosine by regulating and interacting with METTL1.

  2024cites this paper
• Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumors

  2024cites this paper
• M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets

  2024cites this paper
• Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment

  2024cites this paper
• Tumorigenesis Caused by Aberrant Expression of GANP, a Central Component in the Mammalian TREX-2 Complex—Lessons from Transcription-Coupled DNA Damages

  2024cites this paper
• A novel m7G-related miRNA prognostic signature for predicting clinical outcome and immune microenvironment in colon cancer

  2024cites this paper
• A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell Carcinoma

  2024cites this paper
• Cilia defects upon loss of WDR4 are linked to proteasomal hyperactivity and ubiquitin shortage

  2024cites this paper
• Cancer‐associated fibroblasts promote the proliferation and metastasis of colon cancer by mediating the RLIM/PML axis through paracrine COMP

  2024cites this paper
• m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma

  2023cites this paper
• Advances in post-translational modifications of proteins and cancer immunotherapy

  2023cites this paper
• Biological roles of RNA m7G modification and its implications in cancer

  2023cites this paper
• WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB2

  2023cites this paper
• PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target

  2023influential citation
• Wdr4 promotes cerebellar development and locomotion through Arhgap17-mediated Rac1 activation

  2023influential citation
• Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role

  2023cites this paper
• E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities.

  2023cites this paper
• NIR-II fluorescence and PA imaging guided activation of STING pathway in photothermal therapy for boosting cancer immunotherapy by theranostic thermosensitive liposomes.

  2023cites this paper
• Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance

  2023cites this paper
• NIR-II-absorbing diimmonium polymer agent achieves excellent photothermal therapy with induction of tumor immunogenic cell death

  2023cites this paper
• An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer

  2023cites this paper
• Identification and verification of m7G-Related genes as biomarkers for prognosis of sarcoma

  2023cites this paper
• Protein sumoylation in normal and cancer stem cells

  2022cites this paper
• PML isoforms: a molecular basis for PML pleiotropic functions.

  2022cites this paper
• Post-translational Modification in Control of SIRT1 Stability during DNA Damage Response

  2022cites this paper
• The potential role of N7-methylguanosine (m7G) in cancer

  2022cites this paper
• Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review)

  2022cites this paper
• Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

  2022cites this paper
• Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint

  2022cites this paper
• The pattern of expression and prognostic value of key regulators for m7G RNA methylation in hepatocellular carcinoma

  2022cites this paper
• Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers

  2022cites this paper
• A Novel m7G-Related Genes-Based Signature with Prognostic Value and Predictive Ability to Select Patients Responsive to Personalized Treatment Strategies in Bladder Cancer

  2022cites this paper
• A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma

  2022cites this paper
• PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment

  2022cites this paper
• TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets.

  2021cites this paper
• A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML)

  2021cites this paper
• Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer

  2021cites this paper
• Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy.

  2021cites this paper
• Promyelocytic leukemia protein targets MK2 to promote cytotoxicity

  2021cites this paper
• Usp11 controls cortical neurogenesis and neuronal migration through Sox11 stabilization

  2021cites this paper
• Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy

  2021cites this paper
• Cullin 4-DCAF Proteins in Tumorigenesis.

  2020cites this paper
• WD40 protein Wuho controls germline homeostasis via TRIM-NHL tumor suppressor Mei-p26 in Drosophila

  2020cites this paper
• Integrative characterization and validation of tumor-associated immune signature combined with immune-infiltration analysis in clear cell renal cell carcinoma

  2020cites this paper
• Assessment of hazard immune-related genes and tumor immune infiltrations in renal cell carcinoma.

  2020cites this paper
• MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma

  2020cites this paper
• PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy.

  2020cites this paper
• Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy.

  2020cites this paper
• Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma

  2020cites this paper
• Targeting the CD73-adenosine axis in immuno-oncology.

  2019cites this paper
• Oxidized low density lipoprotein receptor 1 promotes lung metastases of osteosarcomas through regulating the epithelial-mesenchymal transition

  2019cites this paper
• Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies

  2019cites this paper
• Multilevel defects in the hematopoietic niche in essential thrombocythemia

  2019cites this paper
• Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation

  2019cites this paper
• Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

  2019cites this paper
• The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

  2019cites this paper
• PML degradation fosters an immunosuppressive and pro-metastatic tumor microenvironment

  2017cites this paper